GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » Revenue

Hyphens Pharma International (SGX:1J5) Revenue : S$156.3 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International Revenue?

Hyphens Pharma International's revenue for the six months ended in Jun. 2023 was S$74.7 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2023 was S$156.3 Mil. Hyphens Pharma International's Revenue per Share for the six months ended in Jun. 2023 was S$0.24. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was S$0.50.

During the past 12 months, the average Revenue per Share Growth Rate of Hyphens Pharma International was 8.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 8 years, Hyphens Pharma International's highest 3-Year average Revenue per Share Growth Rate was 18.70% per year. The lowest was -1.50% per year. And the median was 5.70% per year.


Hyphens Pharma International Revenue Historical Data

The historical data trend for Hyphens Pharma International's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International Revenue Chart

Hyphens Pharma International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Revenue
Get a 7-Day Free Trial 120.93 119.44 120.98 125.88 162.32

Hyphens Pharma International Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.81 62.08 80.70 81.61 74.71

Competitive Comparison of Hyphens Pharma International's Revenue

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyphens Pharma International's Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's Revenue distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's Revenue falls into.



Hyphens Pharma International Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$156.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyphens Pharma International  (SGX:1J5) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Hyphens Pharma International Revenue Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyphens Pharma International (SGX:1J5) Business Description

Traded in Other Exchanges
N/A
Address
16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines